, Tracking Stock Market Picks
Enter Symbol:
Vivus, Inc. (VVUS) [hlAlert]

down 84.62 %

Vivus, Inc. (VVUS) rated Buy by Merriman

Posted on: Tuesday,  Jul 28, 2009  8:25 AM ET by Merriman

Merriman rated Buy Vivus, Inc. (NASDAQ: VVUS) on 07/28/2009, when the stock price was $7.22. Since
then, Vivus, Inc. has lost 84.63% as of 01/25/2016's recent price of $1.11.
If you would have followed this Merriman's recommendation on VVUS, you would have lost 84.62% of your investment in 2372 days.

Vivus, Inc. is a leader in the development and commercialization of innovative therapies for the treatment of sexual dysfunction and urologic disorders in men and women. They develop and market the product MUSE and the medical device ACTIS, two innovations in the treatment of erectile dysfunction. The company has partnered with Abbott Laboratories for the international marketing and distribution of its male erectile dysfunction products. VIVUS also has research and development programs in premature ejaculation and erectile dysfunction. (Company Press Release)

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/28/2009 8:25 AM Buy
as of 12/31/2009
1 Week down  -11.98 %
1 Month up  7.63 %
3 Months down  -16.12 %
1 YTD up  21.05 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy